BIOMAT Database Logo BIOMAT Database Logo

A benzylamine oxidase distinct from monoamine oxidase B--widespread distribution in man and rat. 1978

R Lewinsohn, and K Böhm, and V Glover, and M Sandler

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001595 Benzylamine Oxidase An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide. Clorgyline-Resistant Amine Oxidase,Amine Oxidase, Clorgyline-Resistant,Clorgyline Resistant Amine Oxidase,Oxidase, Benzylamine,Oxidase, Clorgyline-Resistant Amine
D012642 Selegiline A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl. Deprenalin,Deprenil,Deprenyl,E-250,Eldepryl,Emsam,Humex,Jumex,L-Deprenyl,Selegiline Hydrochloride,Selegiline Hydrochloride, (R)-Isomer,Selegiline Hydrochloride, (R,S)-Isomer,Selegiline Hydrochloride, (S)-Isomer,Selegiline, (R)-Isomer,Selegiline, (R,S)-Isomer,Selegiline, (S)-Isomer,Selegyline,Yumex,Zelapar,E 250,E250

Related Publications

R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Development of benzylamine oxidase and monoamine oxidase A and B in man.
May 1980, Biochemical pharmacology,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
[Serum monoamine oxidase (benzylamine oxidase) isozyme].
February 1973, Rinsho byori. The Japanese journal of clinical pathology,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem.
May 1988, Neuroscience,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver.
December 1980, The Journal of pharmacy and pharmacology,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
A coupled peroxidatic oxidation technique for the histochemical localization of monoamine oxidase A and B and benzylamine oxidase.
July 1979, Histochemistry,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Distinct monoamine oxidase A and B populations in primate brain.
October 1985, Science (New York, N.Y.),
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Dopamine is a monoamine oxidase B substrate in man.
January 1977, Nature,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Platelet monoamine oxidase and blood plasma benzylamine oxidase activity in cirrhotic patients.
August 1982, Bollettino della Societa italiana di biologia sperimentale,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
[Monoamine oxidase (XXXVI). Characteristics of benzylamine oxidase in the dog serum].
July 1975, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R Lewinsohn, and K Böhm, and V Glover, and M Sandler
Platelet monoamine oxidase, plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients.
April 1977, Medical biology,
Copied contents to your clipboard!